CAMBRIDGE, Mass. - April 29, 2026. Researchers at the Massachusetts Institute of Technology have introduced Bioinspired123D, ...
Target identification is a critical and challenging step in drug discovery, with only a small fraction of human genes considered druggable and even fewer successfully targeted by approved therapies.
KAUST researchers have presented a 'super transformer' AI architecture designed to integrate diverse biological data into a single analytical model. The system could connect genetic changes to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results